- Dai-Ichi Life reported a net income of 97.94 billion yen for the second quarter.
- The company maintains its net income forecast for the year at 323.00 billion yen, below the market estimate of 350.13 billion yen.
- Projected net sales remain at 8.92 trillion yen, while estimates are higher at 10.33 trillion yen.
- Dai-Ichi Life plans to distribute a dividend of 122.00 yen per share, slightly below the estimated 125.69 yen.
- Analyst ratings for Dai-Ichi Life include 8 ‘buy’ recommendations, 5 ‘hold’ recommendations, and 1 ‘sell’.
“`
A look at Dai Ichi Life Insurance Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 5 | |
| Growth | 3 | |
| Resilience | 4 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 4.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Analysts are optimistic about the long-term prospects of Dai Ichi Life Insurance, as indicated by its Smartkarma Smart Scores. With strong scores in Dividend, Resilience, and Momentum, the company is positioned well for sustainable growth and stability.
Dai Ichi Life Insurance‘s solid Value score further solidifies its attractiveness to investors seeking undervalued opportunities. Although Growth is rated slightly lower, the company’s diverse range of insurance products tailored to various life stages positions it as a reliable choice for both individuals and groups.
### The Dai-ichi Life Insurance Company Ltd. underwrites and sells life, health and annuity insurance to groups and individuals. The Company offers a wide variety of insurance products to suit different needs, ranging from children’s school tuition to emergency funds for the elderly. ###
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
